Upperton has unveiled a new brand identity at CPHI Milan, marking a significant milestone in the company's evolution into a specialist, end-to-end contract developme...

ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, and The Protein Society, an international, not-for-profit, scho...

Booming markets for GLP-1 drugs pose special challenges to pharmaceutical manufacturers. For this purpose, Schreiner MediPharm, a leading developer and manufacturer ...

 Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organisation), today reported interim results from a clinical study i...

Biocon has secured a 10-year PDP allocation for pertuzumab in Brazil through a partnership with Bahiafarma and Bionovis, covering around 70% of the country’s public-...

COVID-19 can awaken dormant viruses that lie hidden in the body for life, even in people with otherwise healthy immune systems, according to a study of more than 1,1...

Qinecsa, the global pharmacovigilance specialist, has been selected as technology partner for AfriVigilance, the African Medicines Agency’s (AMA) new continent-wide ...

AstraZeneca’s Etcamah has received FDA accelerated approval for ctDNA-guided treatment in HR-positive, HER2-negative breast cancer with ESR1 mutations. The decision ...

CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and clinical data quality oversight software, today announced the general availability of th...

Growing demand for biologics, advanced therapies and specialist aseptic fill-finish expertise is driving continued expansion across the pharmaceutical outsourcing se...